Background and purpose: While the 5-HT and Rho-kinase ( ROCK) pathways have been implicated in the development of pulmonary arterial hypertension (PAH), the nature of any interactions between them remain unclear. This study investigated a role for ROCK in 5-HT-regulated proliferative responses in lung fibroblasts in vivo and in vitro. Experimental approach: PAH was examined in mice over-expressing human 5-HT transporters (SERT+), from which pulmonary artery fibroblasts (PFs) were isolated to assess ROCK expression. In vitro analysis of 5-HT signalling employed CCL39 hamster lung fibroblasts. Key results: ROCK inhibition ablated increased pulmonary remodelling and hypertension observed in SERT+ mice, and ROCK1/2 protein levels were ele...
Rationale: Rats dosed with the vascular endothelial growth factor (VEGF) inhibitor Sugen 5416 (Su), ...
Heightened expression of the S100 calcium–binding protein, S100A4/Mts1, is observed in pulmonary vas...
Rationale: Enhanced proliferation and impaired apoptosis of pulmonary arterial vascular smooth muscl...
ABSTRACT Pulmonary arterial hypertension (PAH) is a rare and progressive disease characterised by i...
ABSTRACT Pulmonary arterial hypertension (PAH) is a rare and progressive disease characterised by in...
<b>Aims</b> A mechanism for co-operation between the serotonin (5-hydroxytryptamine, 5-H...
Aims A mechanism for co-operation between the serotonin (5-hydroxytryptamine, 5-HT) transporter and ...
Pulmonary arterial hypertension (PAH) is a devastating disease characterized by progressive elevatio...
Free to read\ud \ud Pulmonary arterial hypertension (PAH) is a progressive disease characterized by ...
9 pagesInternational audienceBACKGROUND: Progression of pulmonary hypertension (PH) is associated wi...
RATIONALE: RhoA and Rho kinase contribute to pulmonary vasoconstriction and vascular remodeling in p...
Increased synthesis of serotonin and/or activity of serotonin in pulmonary arteries has been implica...
Objective: Serotonin can induce human pulmonary artery smooth muscle cell (hPASMC) proliferation thr...
International audiencePulmonary arterial hypertension (PAH) is a progressive disease characterized b...
International audienceIn lung vasculature, reversible constriction of smooth muscle cells exists in ...
Rationale: Rats dosed with the vascular endothelial growth factor (VEGF) inhibitor Sugen 5416 (Su), ...
Heightened expression of the S100 calcium–binding protein, S100A4/Mts1, is observed in pulmonary vas...
Rationale: Enhanced proliferation and impaired apoptosis of pulmonary arterial vascular smooth muscl...
ABSTRACT Pulmonary arterial hypertension (PAH) is a rare and progressive disease characterised by i...
ABSTRACT Pulmonary arterial hypertension (PAH) is a rare and progressive disease characterised by in...
<b>Aims</b> A mechanism for co-operation between the serotonin (5-hydroxytryptamine, 5-H...
Aims A mechanism for co-operation between the serotonin (5-hydroxytryptamine, 5-HT) transporter and ...
Pulmonary arterial hypertension (PAH) is a devastating disease characterized by progressive elevatio...
Free to read\ud \ud Pulmonary arterial hypertension (PAH) is a progressive disease characterized by ...
9 pagesInternational audienceBACKGROUND: Progression of pulmonary hypertension (PH) is associated wi...
RATIONALE: RhoA and Rho kinase contribute to pulmonary vasoconstriction and vascular remodeling in p...
Increased synthesis of serotonin and/or activity of serotonin in pulmonary arteries has been implica...
Objective: Serotonin can induce human pulmonary artery smooth muscle cell (hPASMC) proliferation thr...
International audiencePulmonary arterial hypertension (PAH) is a progressive disease characterized b...
International audienceIn lung vasculature, reversible constriction of smooth muscle cells exists in ...
Rationale: Rats dosed with the vascular endothelial growth factor (VEGF) inhibitor Sugen 5416 (Su), ...
Heightened expression of the S100 calcium–binding protein, S100A4/Mts1, is observed in pulmonary vas...
Rationale: Enhanced proliferation and impaired apoptosis of pulmonary arterial vascular smooth muscl...